BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9153209)

  • 1. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.
    Horn IR; van den Berg BM; van der Meijden PZ; Pannekoek H; van Zonneveld AJ
    J Biol Chem; 1997 May; 272(21):13608-13. PubMed ID: 9153209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties.
    Neels JG; van Den Berg BM; Lookene A; Olivecrona G; Pannekoek H; van Zonneveld AJ
    J Biol Chem; 1999 Oct; 274(44):31305-11. PubMed ID: 10531329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ
    J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin.
    Vash B; Phung N; Zein S; DeCamp D
    Blood; 1998 Nov; 92(9):3277-85. PubMed ID: 9787164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone.
    Obermoeller LM; Warshawsky I; Wardell MR; Bu G
    J Biol Chem; 1997 Apr; 272(16):10761-8. PubMed ID: 9099728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
    Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP). A conserved acidic residue in the complement-type repeats is important for recognition of RAP.
    Andersen OM; Christensen LL; Christensen PA; Sørensen ES; Jacobsen C; Moestrup SK; Etzerodt M; Thogersen HC
    J Biol Chem; 2000 Jul; 275(28):21017-24. PubMed ID: 10747921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of ligand binding to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that lipoprotein lipase and the carboxyl-terminal domain of the receptor-associated protein bind to the same site.
    Nielsen MS; Nykjaer A; Warshawsky I; Schwartz AL; Gliemann J
    J Biol Chem; 1995 Oct; 270(40):23713-9. PubMed ID: 7559542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
    Bu G; Maksymovitch EA; Schwartz AL
    J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein.
    Willnow TE; Orth K; Herz J
    J Biol Chem; 1994 Jun; 269(22):15827-32. PubMed ID: 7515061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms.
    Mikhailenko I; Considine W; Argraves KM; Loukinov D; Hyman BT; Strickland DK
    J Cell Sci; 1999 Oct; 112 ( Pt 19)():3269-81. PubMed ID: 10504332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sites within the 39-kDa protein important for regulating ligand binding to the low-density lipoprotein receptor-related protein.
    Warshawsky I; Bu G; Schwartz AL
    Biochemistry; 1995 Mar; 34(10):3404-15. PubMed ID: 7533537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein.
    Bu G; Geuze HJ; Strous GJ; Schwartz AL
    EMBO J; 1995 May; 14(10):2269-80. PubMed ID: 7774585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
    J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein.
    Bu G; Rennke S
    J Biol Chem; 1996 Sep; 271(36):22218-24. PubMed ID: 8703036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats.
    Moestrup SK; Holtet TL; Etzerodt M; Thøgersen HC; Nykjaer A; Andreasen PA; Rasmussen HH; Sottrup-Jensen L; Gliemann J
    J Biol Chem; 1993 Jun; 268(18):13691-6. PubMed ID: 7685767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
    Iadonato SP; Bu G; Maksymovitch EA; Schwartz AL
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):867-75. PubMed ID: 8280086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.